SCHEMBL29821988

SCHEMBL29821988

Cc1ccc(C)n1-c1cc(Cl)c(Oc2ccc(=O)n(Cc3cccc(C(F)(F)F)c3)c2)c(Cl)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPBWR1 P48145 2/20 0.48
▸ MAPT P10636 4/20 0.45
▸ GAA P10253 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ MKNK1 Q9BUB5 2/20 0.42
▸ MKNK2 Q9HBH9 2/20 0.42
▸ P2RX7 Q99572 2/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ LMNA P02545 3/20 0.41
▸ TP53 P04637 1/20 0.40
▸ RXFP1 Q9HBX9 1/20 0.40
▸ MCHR1 Q99705 1/20 0.39
▸ MAPK1 P28482 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24819271 1.00 NPBWR1 (0.48) NPBWR1MAPTGAASMN1; SMN2MKNK1
SCHEMBL23168653 0.85 MAPT (0.47) NPBWR1MAPTP2RX7LMNATP53
SCHEMBL29821821 0.85 MAPT (0.47) NPBWR1MAPTP2RX7LMNATP53
SCHEMBL29822136 0.85 NPBWR1 (0.50) NPBWR1MAPTGAASMN1; SMN2MKNK1
SCHEMBL24819269 0.85 NPBWR1 (0.50) NPBWR1MAPTGAASMN1; SMN2MKNK1
SCHEMBL23168748 0.85 P2RX7 (0.37) NPBWR1MAPTP2RX7L3MBTL1LMNA
SCHEMBL24819258 0.84 NPBWR1 (0.39) NPBWR1P2RX7L3MBTL1MCHR1
SCHEMBL23168941 0.83 THRB (0.38) NPBWR1MAPTSMN1; SMN2P2RX7LMNA
SCHEMBL23168772 0.83 MAPT (0.43) NPBWR1MAPTGAAP2RX7LMNA
SCHEMBL23168950 0.82 P2RX7 (0.40) MAPTGAAP2RX7LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12617769-B2 Chemical compound as thyroid hormone beta receptor agonist and use thereof SUNSHINE LAKE PHARMA CO., LTD. (CN) 2026-05-05 — — US disclosed
US-20220411400-A1 CHEMICAL COMPOUND AS THYROID HORMONE BETA RECEPTOR AGONIST AND USE THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2022-12-29 — — US disclosed
EP-4036090-A1 CHEMICAL COMPOUND AS THYROID HORMONE BETA RECEPTOR AGONIST AND USE THEREOF Sunshine Lake Pharma Co., Ltd. (CN) 2022-08-03 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220411400-A1 CHEMICAL COMPOUND AS THYROID HORMONE BETA RECEPTOR AGONIST AND USE THEREOF THRB, TSHR, THRA NPBWR1 336/4885MAPT 1873/4885GAA 4093/4885
US-12617769-B2 Chemical compound as thyroid hormone beta receptor agonist and use thereof THRB, TSHR, THRA NPBWR1 267/4885MAPT 2264/4885GAA 4795/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback